Matinas BioPharma Holdings (MTNB) Non-cash Items (2017 - 2023)
Matinas BioPharma Holdings (MTNB) reported Non-cash Items of $22000.0 for Q4 2023, down 75.56% year-over-year from $90000.0 in Q4 2022, and down 75.56% quarter-over-quarter from $90000.0 in Q4 2022.
Matinas BioPharma Holdings (MTNB) Non-cash Items (2017 - 2023) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has 7 years of Non-cash Items data on file, last reported at $22000.0 in Q4 2023.
- Non-cash Items for Q4 2023 came in at $22000.0, down 75.56% year-over-year; the trailing twelve-month figure through Dec 2023 was $22000.0 (down 75.56% YoY), and the FY2023 annual result was $22000.0, down 75.56% from the prior year.
- Non-cash Items retreated to $22000.0 in Q4 2023 per MTNB's latest filing, from $90000.0 in the prior quarter.
- Over five years, Non-cash Items peaked at $21.7 million in Q4 2019 and troughed at $2500.0 in Q4 2021.
- A 5-year average of $4.4 million and a median of $1.0 million in 2019 frame the typical range for Non-cash Items.
- The sharpest annual moves came in 2019 and 2021: Non-cash Items surged 5900.0% in 2019, then tumbled 99.97% in 2021.
- A 5-year view of Non-cash Items shows it stood at $21.7 million in 2019, then tumbled by 63.13% to $8.0 million in 2020, then plunged by 99.97% to $2500.0 in 2021, then surged by 3500.0% to $90000.0 in 2022, then tumbled by 75.56% to $22000.0 in 2023.
- Business Quant data shows MTNB's Non-cash Items at $22000.0 in Q4 2023, $90000.0 in Q4 2022, and $2500.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 22,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 90,000.00 |
| Dec 31, 2022 | 90,000.00 |
| Dec 31, 2021 | 2,500.00 |
| Dec 31, 2021 | 2,500.00 |
| Dec 31, 2020 | 8.00 Mn |
| Dec 31, 2020 | 8.00 Mn |
| Dec 31, 2019 | 21.70 Mn |
| Dec 31, 2019 | 21.70 Mn |
| Sep 30, 2019 | 600,000.00 |
| Sep 30, 2019 | 600,000.00 |
| Jun 30, 2019 | 1.50 Mn |
| Jun 30, 2019 | 1.50 Mn |
| Mar 31, 2019 | 3.40 Mn |
| Mar 31, 2019 | 3.40 Mn |
| Dec 31, 2018 | 500,000.00 |
| Dec 31, 2018 | 500,000.00 |
| Sep 30, 2018 | 1.50 Mn |
| Sep 30, 2018 | 1.50 Mn |